You are viewing an archive version of the PSNC website taken on 18th April 2013. This site is not updated, and may be out of date or relate to old NHS structures.
For updated and current information, please visit our new website at www.psnc.org.uk
Skip Navigation
PSNC Home Page
Advanced Search
.

Pharmaceutical Services Negotiating Committee

Drug Tariff News

December NCSO/Price concessions updated

December 2012

Price concessions- These prices are automatically applied to prescriptions there is no need for any endorsement.

  • Nitrazepam 5mg tablets (28 tablets)- £2.80
  • Tolbutamide 500mg tablets(28 tablets) - £24.56

NCSO status is granted for December 2012 for the following:

Isosorbide mononitrate 20mg tablets (NEW)
Moclobemide 300mg tablets (NEW)
Nifedipine 5mg capsules
Nifedipine 10mg capsules
Selegiline 10mg tablets (NEW)
Temazepam 10mg tablets
Temazepam 20mg tablets
Trazodone 50mg capsules
Trazodone 100mg capsules
Trazodone 150mg tablets

It is essential that contractors endorse the prescription fully with the letters ‘NCSO' and full details of the product dispensed (e.g. manufacturer or supplier or brand name and pack size. If a particular supplier's product is not listed with a price on the NHS RxS pricing system, pharmacies must also endorse the price paid (before discount and ex VAT)). The endorsement must also be signed or initialed and dated. If any of this information is missing, payment will be based on the Drug Tariff price rather than the endorsed product.

Please note that PSNC cannot provide details of generic products that are suspected of being affected by generic supply problems unless and until the Department of Health grants a concession.

If you have problems obtaining a Part VIII product or problems obtaining the product at the set Drug Tariff price, please report the issue to PSNC using the online feedback form on the PSNC Website. If you have been able to source the product, please provide full details of the supplier and price paid. PSNC will investigate the extent of the problem and if appropriate discuss the issue with the Department of Health.

Posted 14 December 2012

< Back